Kidd Parris M
Altern Med Rev. 2009 Mar;14(1):14-35.
Brain injury from ischemic stroke can be devastating, but full brain restoration is feasible. Time until treatment is critical; rapid rate of injury progression, logistical and personnel constraints on neurological and cardiovascular assessment, limitations of recombinant tissue plasminogen activator (rtPA) for thrombolysis, anticoagulation and antiplatelet interventions, and neuroprotection all affect outcome. Promising acute neuroprotectant measures include albumin, magnesium, and hypothermia. Long-term hyperbaric oxygen therapy (HBOT) is safe and holds great promise. Eicosanoid and cytokine down-regulation by omega-3 nutrients docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) may help quench stroke inflammation. C-reactive protein (CRP), an inflammatory biomarker and stroke-recurrence predictor, responds favorably to krill oil (a phospholipid-DHA/EPA-astaxanthin complex). High homocysteine (Hcy) is a proven predictor of stroke recurrence and responds to folic acid and vitamin B12. Vitamin E may lower recurrence for individuals experiencing high oxidative stress. Citicoline shows promise for acute neuroprotection. Glycerophosphocholine (GPC) is neuroprotective and supports neuroplasticity via nerve growth factor (NGF) receptors. Stem cells have shown promise for neuronal restoration in randomized trials. Endogenous brain stem cells can migrate to an ischemic injury zone; exogenous stem cells once transplanted can migrate (home) to the stroke lesion and provide trophic support for cortical neuroplasticity. The hematopoietic growth factors erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) have shown promise in preliminary trials, with manageable adverse effects. Physical and mental exercises, including constraint-induced movement therapy (CIMT) and interactive learning aids, further support brain restoration following ischemic stroke. Brain plasticity underpins the function-driven brain restoration that can occur following stroke.
缺血性中风导致的脑损伤可能是毁灭性的,但全脑恢复是可行的。治疗前的时间至关重要;损伤进展速度快、神经和心血管评估存在后勤及人员限制、重组组织型纤溶酶原激活剂(rtPA)溶栓的局限性、抗凝和抗血小板干预措施以及神经保护都影响预后。有前景的急性神经保护措施包括白蛋白、镁和低温。长期高压氧治疗(HBOT)安全且前景广阔。ω-3营养物质二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)对类花生酸和细胞因子的下调作用可能有助于减轻中风炎症。C反应蛋白(CRP)是一种炎症生物标志物和中风复发预测指标,对磷虾油(一种磷脂-DHA/EPA-虾青素复合物)反应良好。高同型半胱氨酸(Hcy)是已证实的中风复发预测指标,对叶酸和维生素B12有反应。维生素E可能降低高氧化应激个体的中风复发率。胞磷胆碱对急性神经保护有前景。甘油磷酸胆碱(GPC)具有神经保护作用,并通过神经生长因子(NGF)受体支持神经可塑性。干细胞在随机试验中显示出神经元恢复的前景。内源性脑干细胞可迁移至缺血损伤区;外源性干细胞一旦移植可迁移(归巢)至中风病灶并为皮质神经可塑性提供营养支持。造血生长因子促红细胞生成素(EPO)和粒细胞集落刺激因子(G-CSF)在初步试验中显示出前景,且不良反应可控。包括强制性运动疗法(CIMT)和交互式学习辅助工具在内的身心锻炼进一步支持缺血性中风后的脑恢复。脑可塑性是中风后功能驱动的脑恢复的基础。